NFKB1 and neoplasm: Studies have demonstrated that METTL3 enhances tumor cell proliferation and invasion through the MYC, inhibitor of nuclear factor kappa-B kinase subunit beta (IKBKB), and RELA proto-oncogene, NF-kB subunit (RELA) signaling pathways.